Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Zhou, Esther H.
4849  Ergebnisse:
Personensuche X
?
1

Prescriber perceptions of boxed warnings: A qualitative stu..:

Ingersoll, Rachel N. ; Bui, Elise T. ; Coleman, Blair..
Pharmacoepidemiology and Drug Safety.  33 (2024)  3 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

How Do Risk Evaluation and Mitigation Strategies Impact Cli..:

Sarpatwari, Ameet ; Lu, Zhigang ; Russo, Massimiliano...
Clinical Pharmacology & Therapeutics.  115 (2024)  6 - p. 1293-1303 , 2024
Link: https://doi.org/10.1002/..
 
?
3

Trends in Use and Evidence of Adherence to Risk Evaluation ..:

Mahesri, Mufaddal ; Sarpatwari, Ameet ; Huybrechts, Krista F....
Drug Safety.  , 2024
Link: https://doi.org/10.1007/..
 
?
4

The Risk Evaluation and Mitigation Strategy (REMS) Public D..:

Toyserkani, Gita A. ; Lee, Joann H. ; Zhou, Esther H.
Pharmaceutical Medicine.  37 (2023)  5 - p. 349-353 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Correction to: The Risk Evaluation and Mitigation Strategy ..:

Toyserkani, Gita A. ; Lee, Joann H. ; Zhou, Esther H.
Pharmaceutical Medicine.  37 (2023)  5 - p. 355-355 , 2023
Link: https://doi.org/10.1007/..
 
?
6

A Multi-modal Approach to Evaluate the Impact of Risk Evalu..:

Sarpatwari, Ameet ; Mitra-Majumdar, Mayookha ; Bykov, Katsiaryna...
Drug Safety.  44 (2021)  7 - p. 743-751 , 2021
Link: https://doi.org/10.1007/..
 
?
7

Validity of ICD‐10‐CM diagnoses to identify hospitalization..:

Lo Re III, Vincent ; Carbonari, Dena M. ; Jacob, Jerry...
Pharmacoepidemiology and Drug Safety.  30 (2021)  7 - p. 899-909 , 2021
Link: https://doi.org/10.1002/..
 
?
8

Trend changes of national zolpidem users and exposure cases..:

Zhou, Esther H. ; Feng, Zhou ; Pinnow, Ellen...
Pharmacoepidemiology and Drug Safety.  30 (2021)  11 - p. 1551-1559 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Changes in emergency department visits for zolpidem‐attribu..:

Geller, Andrew I. ; Zhou, Esther H. ; Budnitz, Daniel S...
Pharmacoepidemiology and Drug Safety.  29 (2020)  3 - p. 352-356 , 2020
Link: https://doi.org/10.1002/..
 
?
10

Multimodal Analysis of FDA Drug Safety Communications: Less..:

Kesselheim, Aaron S. ; Sinha, Michael S. ; Campbell, Eric G....
Drug Safety.  42 (2019)  11 - p. 1287-1295 , 2019
Link: https://doi.org/10.1007/..
 
?
11

Patients' Knowledge of Key Messaging in Drug Safety Communi..:

Kesselheim, Aaron S. ; Sinha, Michael S. ; Rausch, Paula...
Journal of Law, Medicine & Ethics.  47 (2019)  3 - p. 430-441 , 2019
Link: https://doi.org/10.1177/..
 
?
12

Social Media Impact of the Food and Drug Administration's D..:

Sinha, Michael S ; Freifeld, Clark C ; Brownstein, John S...
JMIR Public Health and Surveillance.  4 (2018)  1 - p. e1 , 2018
Link: https://doi.org/10.2196/..
 
?
13

Dosing Recommendations for Quetiapine When Coadministered W..:

Sampson, Mario R. ; Cao, Kelly Y. ; Gish, Paula L....
The Journal of Clinical Pharmacology.  59 (2018)  4 - p. 500-509 , 2018
Link: https://doi.org/10.1002/..
 
?
14

Media Coverage of FDA Drug Safety Communications about Zolp..:

Woloshin, Steve ; Schwartz, Lisa M. ; Dejene, Sara...
Journal of Health Communication.  22 (2017)  5 - p. 365-372 , 2017
Link: https://doi.org/10.1080/..
 
?
15

Long-Term Risk of Acute Myocardial Infarction, Stroke, and ..:

Mosholder, Andrew D ; Lee, Joo-Yeon ; Zhou, Esther H...
American Journal of Epidemiology.  187 (2017)  4 - p. 786-792 , 2017
Link: https://doi.org/10.1093/..
 
1-15